These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4104638)

  • 1. Liver morphology and biochemistry in eight obese patients treated with jejunoileal anastomosis.
    Juhl E; Christoffersen P; Baden H; Quaade F
    N Engl J Med; 1971 Sep; 285(10):543-7. PubMed ID: 4104638
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver changes after jejuno-ileal shunting for massive obesity.
    Thompson RH; Meyerowitz BR
    Surg Forum; 1970; 21():366-7. PubMed ID: 5514766
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein nutrition and liver disease after jejunoileal bypass for morbid obesity.
    Moxley RT; Pozefsky T; Lockwood DH
    N Engl J Med; 1974 Apr; 290(17):921-6. PubMed ID: 4206095
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.
    Korman MG; Hofmann AF; Summerskill WH
    N Engl J Med; 1974 Jun; 290(25):1399-402. PubMed ID: 4133590
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic lipid in morbid obesity. Assessment at and subsequent to jejunoileal bypass.
    Holzbach RT; Wieland RG; Lieber CS; DeCarli LM; Koepke KR; Green SG
    N Engl J Med; 1974 Feb; 290(6):296-9. PubMed ID: 4809283
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic effects of jejunoileal bypass for morbid obesity.
    Brown RG; O'Leary JP; Woodward ER
    Am J Surg; 1974 Jan; 127(1):53-8. PubMed ID: 4808687
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver function and morphology in chronic progressive polyarthritis].
    Rau R; Rondez R; Grob P
    Z Rheumaforsch; 1971; 30(7):205-13. PubMed ID: 4106068
    [No Abstract]   [Full Text] [Related]  

  • 8. Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver.
    Massarrat S; Jordan G; Sahrhage G; Korb G; Bode JC; Dölle W
    Acta Hepatogastroenterol (Stuttg); 1974 Jun; 21(3):176-86. PubMed ID: 4450977
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ergometric studies of body tolerance in patients with chronic liver disease].
    Franken FH; Wiechers B
    Dtsch Med Wochenschr; 1973 Mar; 98(11):528-31. PubMed ID: 4694994
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liver in active hyperthyreosis].
    Meng W; Lorenz G; Eggert H; Meng S; Hampel R; Baufeld W
    Z Gesamte Inn Med; 1973 Dec; 28(24):787-91. PubMed ID: 4130587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liver function in porphyria cutanea tarda. Experiences with 32 patients].
    Pietschmann H; Raab W; Hartl O
    Wien Z Inn Med; 1966 Sep; 47(9):349-62. PubMed ID: 4187166
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of hepatic injury after jejuno-ileal bypass by supplemental jejunostomy feedings.
    McClelland RN; DeShazo CV; Heimbach DM; Eigenbrodt EH; Dowdy AB
    Surg Forum; 1970; 21():368-70. PubMed ID: 4999013
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein supplementation in the management of degenerating liver function after jejunoileal bypass.
    Ackerman NB
    Surg Gynecol Obstet; 1979 Jul; 149(1):8-14. PubMed ID: 451835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal bypass in morbid obesity: long-term metabolic sequelae.
    Kish GF; Parker FW; Joseph WL
    Am Surg; 1975 Dec; 41(12):786-92. PubMed ID: 1081861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical diagnosis of alcoholic fatty liver.
    Devenyi P; Rutherdale J; Sereny G; Olin JS
    Am J Gastroenterol; 1970 Dec; 54(6):597-602. PubMed ID: 5504217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liverfunction and serum concentration of electrolytes in patients operated for morbid obesity (author's transl)].
    Tuszewski M; Woszczyk J; Rushzkowska J
    Zentralbl Chir; 1977; 102(6):351-6. PubMed ID: 868331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of Mallory bodies in the progression of fatty liver into cirrhosis.
    Christoffersen P; Juhl E
    Acta Pathol Microbiol Scand A; 1974 Jul; 82(4):483-6. PubMed ID: 4137298
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sensitivity of laboratory examinations in the diagnosis of chronic inflammatory liver diseases].
    Gros H; Zwirner K
    Med Klin; 1968 Oct; 63(40):1577-9. PubMed ID: 4180933
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic value of laboratory tests in liver disease.
    Tygstrup N
    Scand J Gastroenterol Suppl; 1973; 19():47-50. PubMed ID: 4123936
    [No Abstract]   [Full Text] [Related]  

  • 20. "Lupoid" hepatitis, a nonentity in the spectrum of chronic active liver disease.
    Soloway RD; Summerskill WH; Baggenstoss AH; Schoenfield LJ
    Gastroenterology; 1972 Sep; 63(3):458-65. PubMed ID: 4116064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.